Quarterly Result11 Feb 2026, 10:20 am
Skybiotech Healthcare Ltd to Approve Q3 FY2025-2026 Financial Results on Feb 14, 2026
AI Summary
Skybiotech Healthcare Ltd has announced a Board of Directors meeting on February 14, 2026. The agenda includes the approval of the unaudited financial results and limited review report for the quarter ending on December 31, 2025. This is in accordance with the SEBI (LODR) Regulations, 2015, Regulation 29(1) (a).
Key Highlights
- Skybiotech Healthcare Ltd scheduled a Board of Directors meeting on February 14, 2026
- The meeting aims to approve the unaudited financial results for the quarter ending on December 31, 2025
- The approval also includes the limited review report of the Company for the same quarter
- The announcement is in compliance with the SEBI (LODR) Regulations, 2015, Regulation 29(1) (a)
Price Impact
More from KAPILCO